Table 5.

Urease inhibitory screening results of the synthesized compounds (T₁–T₂₀)

Compounds	% inhibition				IC50 (µg/ml)
	25 (µg/ml)	50 (µg/ml)	75 (µg/ml)	100 (µg/ml)
T1	25.76	47.98	72.9	91.99	51.70
T2	40.45	49.54	55.67	67.57	53.04
T3	28.19	50.00	65.89	79.12	54.01
T4	35.45	49.45	63.67	79.45	50.52
T5	23.34	44.35	70.87	90.87	54.46
T6	38.45	50.34	65.61	80.89	47.02
T7	23.98	46.89	76.09	91.90	52.07
T8	22.45	39.58	68.58	92.67	56.43
T9	33.45	53.67	70.46	92.67	46.34
T10	27.90	46.89	70.90	89.80	51.90
T11	25.00	42.45	68.88	92.67	54.59
T12	43.56	46.57	52.56	61.56	58.06
T13	26.57	48.78	73.98	98.89	50.05
T14	41.70	46.23	50.49	57.78	67.02
T15	29.03	37.14	61.78	73.12	61.04
T16	45.76	49.10	53.87	59.12	52.85
T17	37.91	42.38	57.61	71.42	57.47
T18	40.90	46.79	55.89	67.9	54.30
T19	31.89	47.98	52.98	65.87	63.24
T20	28.98	49.09	69.09	81.90	52.34
Thiourea	29.98	46.76	67.78	76.78	54.25

Italics signifies the most active compound in comparison to the standard compound